Background: The effects of vasoactive drugs, including bronchodilators
, on vascular and pulmonary dynamics are interrelated, complex and dif
ficult to measure, but important because of potential deleterious effe
cts on gas exchange. Methods: To assess the effects of fenoterol at bo
th high and low dose on pulmonary gas exchange in 24 hypoxemic patient
s with stable COPD: fenoterol, 5 mg; fenoterol, 1 mg and ipratropium b
romide, 0.5 mg; ipratropium bromide, 0.5 mg; or matched placebo were n
ebulized in a double-blind, placebo-controlled fashion. Spirometry, ve
ntilation, systemic hemodynamics, and respiratory and inert gases were
measured before and 15, 60, and 120 min after each treatment. Results
: Compared with placebo, heart rate (p<0.002) and cardiac output (p=0.
05) increased after high-dose fenoterol therapy to return to baseline
values by 120 min, Following fenoterol at high dose, mean maximum PaO2
change from baseline decreased by 6.3+/-1.1 mm Hg (SD) and both alveo
lar-arterial oxygen pressure difference (P[A-a]O-2), by 8.3+/-4.0 mm H
g, and ventilation-perfusion (V over dot A/Q over dot) mismatching inc
reased, as evidenced by increments of the dispersion of pulmonary bloo
d now, without reaching significance; likewise, low-dose fenoterol the
rapy increased V over dot A/Q over dot inequalities while both PaO2 an
d P(A-a)O-2 remained unchanged. Conclusions: In this population of COP
D patients, high-dose fenoterol therapy did not significantly increase
heart rate and cardiac output resulting in minor adverse consequences
on arterial oxygenation and V over dot A/Q over dot relationships.